Antabio
Developer of MEM-ANT3310, a next generation antibacterial combination.
4
Funding Rounds
$42.7m
Money raised
Funding
Funding series
Funding Series Analysis
The company Antabio has raised a total of $42.7m in funding over 4 rounds.
Key Insights:
- Antabio December 2023 Series B Funding Round: $27m
- Antabio Sas Series A round, July 2018: $14.6m
- Antabio December 2014 Seed Funding Round: $98.14k
- Antabio February 2011 Seed Funding Round: $1m
Antabio December 2023 Series B Funding Round
$27m
Antabio Sas Series A round, July 2018
$14.6m
Antabio December 2014 Seed Funding Round
$98.14k
Antabio February 2011 Seed Funding Round
$1m
Industries
Antabio is active in the following industries: